{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:50:22Z","timestamp":1792155022345,"version":"4.4.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"DOI":"10.1007\/s40119-026-00480-6","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:10:55Z","timestamp":1792152655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anticoagulation in Mechanical Circulatory Support: Contemporary Challenges and Future Directions in Cardiovascular Pharmacotherapy"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1549-0941","authenticated-orcid":false,"given":"Lama","family":"Alfehaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Alomran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahlam","family":"Althobaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmajeed","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Bahmaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Albulushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"7","key":"480_CR1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.healun.2022.12.004","volume":"42","author":"D Saeed","year":"2023","unstructured":"Saeed D, Feldman D, Banayosy AE, et al. The 2023 International Society for Heart and Lung Transplantation guidelines for mechanical circulatory support: a 10- year update. J Heart Lung Transplant. 2023;42(7):e1\u2013222. https:\/\/doi.org\/10.1016\/j.healun.2022.12.004.","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"480_CR2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/MAT.0000000000001652","volume":"68","author":"ABV McMichael","year":"2022","unstructured":"McMichael ABV, Ryerson LM, Ratano D, Fan E, Faraoni D, Annich GM. 2021 ELSO adult and pediatric anticoagulation guidelines. ASAIO J. 2022;68(3):303\u201310. https:\/\/doi.org\/10.1097\/MAT.0000000000001652.","journal-title":"ASAIO J"},{"issue":"4","key":"480_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.028","volume":"42","author":"AM Bernhardt","year":"2023","unstructured":"Bernhardt AM, Copeland H, Deswal A, et al. The International Society for Heart and Lung Transplantation\/Heart Failure Society of America guideline on acute mechanical circulatory support. J Heart Lung Transplant. 2023;42(4):e1-64. https:\/\/doi.org\/10.1016\/j.healun.2022.10.028.","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"480_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jtha.2022.11.014","volume":"21","author":"J Helms","year":"2023","unstructured":"Helms J, Frere C, Thiele T, et al. Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2023;21(2):373\u201396. https:\/\/doi.org\/10.1016\/j.jtha.2022.11.014.","journal-title":"J Thromb Haemost"},{"issue":"9","key":"480_CR5","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1097\/CCM.0000000000005033","volume":"49","author":"TG Seelhammer","year":"2021","unstructured":"Seelhammer TG, Bohman JK, Schulte PJ, Hanson AC, Aganga DO. Comparison of bivalirudin versus heparin for maintenance systemic anticoagulation during adult and pediatric extracorporeal membrane oxygenation. Crit Care Med. 2021;49(9):1481\u201392. https:\/\/doi.org\/10.1097\/CCM.0000000000005033.","journal-title":"Crit Care Med"},{"issue":"2","key":"480_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/MAT.0000000000001808","volume":"69","author":"PM Wieruszewski","year":"2023","unstructured":"Wieruszewski PM, Macielak SA, Nei SD, et al. Heparin versus bivalirudin for anticoagulation in adult extracorporeal membrane oxygenation: a systematic review and meta-analysis. ASAIO J. 2023;69(2):137\u201344. https:\/\/doi.org\/10.1097\/MAT.0000000000001808.","journal-title":"ASAIO J"},{"issue":"6","key":"480_CR7","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1111\/bcp.15251","volume":"88","author":"MJ Li","year":"2022","unstructured":"Li MJ, Shi JY, Zhang JH. Bivalirudin vs. heparin in paediatric and adult patients on extracorporeal membrane oxygenation: a meta-analysis. Br J Clin Pharmacol. 2022;88(6):2605\u201316. https:\/\/doi.org\/10.1111\/bcp.15251.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"480_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/08971900221143406","volume":"37","author":"K Kido","year":"2024","unstructured":"Kido K, Kabulski GM, Szymanski TW, Shiga T, Shimizu M, Hashiguchi M. Meta-analysis comparing bivalirudin versus. Unfractionated heparin in adult patients with extracorporeal membrane oxygenation. J Pharm Pract. 2024;37(2):429\u201334. https:\/\/doi.org\/10.1177\/08971900221143406.","journal-title":"J Pharm Pract"},{"issue":"33","key":"480_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000042696","volume":"104","author":"Y Hu","year":"2025","unstructured":"Hu Y, Yu L, Yang W. Effectiveness and safety of bivalirudin anticoagulation therapy in adult patients receiving extracorporeal membrane oxygenation: a systematic review and meta-analysis. Medicine (Baltimore). 2025;104(33):e42696. https:\/\/doi.org\/10.1097\/MD.0000000000042696.","journal-title":"Medicine (Baltimore)"},{"key":"480_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.771563","volume":"13","author":"M Ma","year":"2022","unstructured":"Ma M, Liang S, Zhu J, et al. The efficacy and safety of bivalirudin versus heparin in the anticoagulation therapy of extracorporeal membrane oxygenation: a systematic review and meta-analysis. Front Pharmacol. 2022;13:771563. https:\/\/doi.org\/10.3389\/fphar.2022.771563.","journal-title":"Front Pharmacol"},{"issue":"5","key":"480_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1177\/10600280251371081","volume":"60","author":"T Lofy","year":"2026","unstructured":"Lofy T, Juul J, Duewell B, et al. Retrospective, single-center cohort study of bivalirudin compared to unfractionated heparin in patients receiving extracorporeal membrane oxygenation. Ann Pharmacother. 2026;60(5):455\u201365. https:\/\/doi.org\/10.1177\/10600280251371081.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"480_CR12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/MAT.0000000000001230","volume":"67","author":"SR Olson","year":"2021","unstructured":"Olson SR, Murphree CR, Zonies D, et al. Thrombosis and bleeding in extracorporeal membrane oxygenation (ECMO) without anticoagulation: a systematic review. ASAIO J. 2021;67(3):290\u20136. https:\/\/doi.org\/10.1097\/MAT.0000000000001230.","journal-title":"ASAIO J"},{"key":"480_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2026.1767978","volume":"13","author":"T Zhang","year":"2026","unstructured":"Zhang T, Cheng L, Cheng Z, Shi A, Shao W. Efficacy of reduced-intensity or no heparin versus standard heparin anticoagulation in patients on extracorporeal membrane oxygenation: a systematic review and meta-analysis. Front Med. 2026;13:1767978. https:\/\/doi.org\/10.3389\/fmed.2026.1767978.","journal-title":"Front Med"},{"issue":"2","key":"480_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4037\/aacnacc2020132","volume":"31","author":"T Williams-Norwood","year":"2020","unstructured":"Williams-Norwood T, Caswell M, Milner B, et al. Design and implementation of an anti\u2013factor Xa heparin monitoring protocol. AACN Adv Crit Care. 2020;31(2):129\u201337. https:\/\/doi.org\/10.4037\/aacnacc2020132.","journal-title":"AACN Adv Crit Care"},{"key":"480_CR15","doi-asserted-by":"publisher","unstructured":"Wikkels\u00f8 A, Wetterslev J, M\u00f8ller AM, Afshari A. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. Cochrane Database Syst Rev. 2016;2016(8):CD007871. https:\/\/doi.org\/10.1002\/14651858.CD007871.pub3","DOI":"10.1002\/14651858.CD007871.pub3"},{"issue":"6","key":"480_CR16","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/TA.0000000000002944","volume":"89","author":"N Bugaev","year":"2020","unstructured":"Bugaev N, Como JJ, Golani G, et al. Thromboelastography and rotational thromboelastometry in bleeding patients with coagulopathy: practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2020;89(6):999\u20131017. https:\/\/doi.org\/10.1097\/TA.0000000000002944.","journal-title":"J Trauma Acute Care Surg"},{"key":"480_CR17","doi-asserted-by":"publisher","unstructured":"Van Edom C, Van Puyvelde T, Jacobs S, Vandenbriele C. Switch to a bicarbonate-based Impella CPTM purge solution in a patient with haemothorax: a case report. Eur Heart J Case Rep. 2023;7(1):ytad022. https:\/\/doi.org\/10.1093\/ehjcr\/ytad022.","DOI":"10.1093\/ehjcr\/ytad022"},{"issue":"6","key":"480_CR18","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1177\/10600280221124156","volume":"57","author":"K Bergen","year":"2023","unstructured":"Bergen K, Sridhara S, Cavarocchi N, Silvestry S, Ventura D. Analysis of bicarbonate-based purge solution in patients with cardiogenic shock supported via Impella ventricular assist device. Ann Pharmacother. 2023;57(6):646\u201352. https:\/\/doi.org\/10.1177\/10600280221124156.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"480_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10047-024-01452-0","volume":"28","author":"S Nagai","year":"2025","unstructured":"Nagai S, Hiraiwa H, Ito R, et al. Usefulness of bicarbonate-based Impella purge solution in a patient with heparin-induced thrombocytopenia: the first case report of long-term management in Japan. J Artif Organs. 2025;28(1):83\u20139. https:\/\/doi.org\/10.1007\/s10047-024-01452-0.","journal-title":"J Artif Organs"},{"key":"480_CR20","doi-asserted-by":"publisher","DOI":"10.1177\/10600280261437140","author":"BA Betts","year":"2026","unstructured":"Betts BA, Moser MJ, Kim JH, Knowles DM, Solomon EJ, Tom A, et al. Comparison of bicarbonate-based versus heparin-based Impella\u00ae purge solution. Ann Pharmacother. 2026. https:\/\/doi.org\/10.1177\/10600280261437140.","journal-title":"Ann Pharmacother"},{"key":"480_CR21","unstructured":"U.S. Food and Drug Administration (FDA). Post-approval surveillance: Impella sodium bicarbonate purge solution. Silver Spring: FDA; 2023. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfPMA\/pma_pas.cfm?c_id=7005&t_id=742088. Accessed 13 Mar 2026."},{"issue":"22","key":"480_CR22","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1001\/jama.2023.23204","volume":"330","author":"MR Mehra","year":"2023","unstructured":"Mehra MR, Netuka I, Uriel N, et al. Aspirin and hemocompatibility events with a left ventricular assist device in advanced heart failure: the ARIES-HM3 randomized clinical trial. JAMA. 2023;330(22):2171. https:\/\/doi.org\/10.1001\/jama.2023.23204.","journal-title":"JAMA"},{"issue":"12","key":"480_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2024.102871","volume":"49","author":"M Mhanna","year":"2024","unstructured":"Mhanna M, Ayyad M, Mortada I, et al. Direct oral anticoagulants versus warfarin in adults with durable left ventricular assist devices: a systematic review and meta-analysis. Curr Probl Cardiol. 2024;49(12):102871. https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102871.","journal-title":"Curr Probl Cardiol"},{"issue":"12","key":"480_CR24","doi-asserted-by":"publisher","first-page":"e182","DOI":"10.1097\/MAT.0000000000002385","volume":"71","author":"M Cherbi","year":"2025","unstructured":"Cherbi M, Vandenbriele C, Baudry G, Delmas C. Apixaban anticoagulation in heartmate 3 left ventricular assist device: a meta-analysis of randomized controlled trials. ASAIO J. 2025;71(12):e182\u20133. https:\/\/doi.org\/10.1097\/MAT.0000000000002385.","journal-title":"ASAIO J"},{"issue":"7","key":"480_CR25","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1007\/s11239-025-03141-y","volume":"58","author":"A Tripoli","year":"2025","unstructured":"Tripoli A, Samaniego MA, Gamarra-Valverde NN, et al. Efficacy and safety of apixaban versus vitamin K antagonists in patients with heartmate 3 fully magnetically levitated left ventricular assist device: a comprehensive meta-analysis. J Thromb Thrombolysis. 2025;58(7):750\u201360. https:\/\/doi.org\/10.1007\/s11239-025-03141-y.","journal-title":"J Thromb Thrombolysis"},{"issue":"8","key":"480_CR26","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.healun.2024.04.065","volume":"43","author":"IB Hollis","year":"2024","unstructured":"Hollis IB, Jennings DL, Krim S, et al. An ISHLT consensus statement on strategies to prevent and manage hemocompatibility related adverse events in patients with a durable, continuous-flow ventricular assist device. J Heart Lung Transplant. 2024;43(8):1199\u2013234. https:\/\/doi.org\/10.1016\/j.healun.2024.04.065.","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"480_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-026-05900-6","volume":"30","author":"H Buscher","year":"2026","unstructured":"Buscher H, Thao LTP, Martucci G, et al. Major haemorrhage and blood product utilisation in patients receiving VA ECMO for cardiogenic shock: a multicentre observational study (OBLEX). Crit Care. 2026;30(1):191. https:\/\/doi.org\/10.1186\/s13054-026-05900-6.","journal-title":"Crit Care"},{"issue":"10552","key":"480_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0140-6736(26)00851-2","volume":"408","author":"OV Minnen","year":"2026","unstructured":"Minnen OV, Lansink-Hartgring AO, van Amstel RBE, vet al. Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial. Lancet. 2026;408(10552):357\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(26)00851-2.","journal-title":"Lancet"},{"issue":"4","key":"480_CR29","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jtcvs.2010.03.046","volume":"141","author":"R John","year":"2011","unstructured":"John R, Long JW, Massey HT, et al. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg. 2011;141(4):932\u20139. https:\/\/doi.org\/10.1016\/j.jtcvs.2010.03.046.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"480_CR30","doi-asserted-by":"crossref","unstructured":"Neal JR, Quintana E, Pike RB, Hoyer JD, Joyce LD, Schears G. Using daily plasma-free hemoglobin levels for diagnosis of critical pump thrombus in patients undergoing ECMO or VAD support. J Extra Corpor Technol. 2015;47(2):103\u20138.","DOI":"10.1051\/ject\/201547103"},{"issue":"07","key":"480_CR31","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1055\/s-0042-1756303","volume":"48","author":"O Volod","year":"2022","unstructured":"Volod O, Wegner J. Viscoelastic testing in the management of adult patients on mechanical circulatory support devices with focus on extracorporeal membrane oxygenation. Semin Thromb Hemost. 2022;48(07):814\u201327. https:\/\/doi.org\/10.1055\/s-0042-1756303.","journal-title":"Semin Thromb Hemost"},{"issue":"13","key":"480_CR32","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/eurheartj\/ehi161","volume":"26","author":"H Thiele","year":"2005","unstructured":"Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26(13):1276\u201383. https:\/\/doi.org\/10.1093\/eurheartj\/ehi161.","journal-title":"Eur Heart J"},{"issue":"4","key":"480_CR33","doi-asserted-by":"publisher","first-page":"e274","DOI":"10.4244\/EIJY21M05_01","volume":"17","author":"A Chieffo","year":"2021","unstructured":"Chieffo A, Dudek D, Hassager C, et al. Joint EAPCI\/ACVC expert consensus document on percutaneous ventricular assist devices. EuroIntervention. 2021;17(4):e274\u201386. https:\/\/doi.org\/10.4244\/EIJY21M05_01.","journal-title":"EuroIntervention"},{"issue":"14","key":"480_CR34","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1161\/CIRCULATIONAHA.111.040220","volume":"125","author":"B Kar","year":"2012","unstructured":"Kar B, Basra SS, Shah NR, Loyalka P. Percutaneous circulatory support in cardiogenic shock: interventional bridge to recovery. Circulation. 2012;125(14):1809\u201317. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.040220.","journal-title":"Circulation"},{"issue":"4","key":"480_CR35","doi-asserted-by":"publisher","DOI":"10.14503\/THIJ-23-8135","volume":"50","author":"EB Yin","year":"2023","unstructured":"Yin EB. Anticoagulation management in temporary mechanical circulatory support devices. Tex Heart Inst J. 2023;50(4):e238135. https:\/\/doi.org\/10.14503\/THIJ-23-8135.","journal-title":"Tex Heart Inst J"},{"issue":"7","key":"480_CR36","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/aor.14525","volume":"47","author":"A Alam","year":"2023","unstructured":"Alam A, Baran DA, Doshi H, et al. Safety and efficacy of ProtekDuo right ventricular assist device: a systemic review. Artif Organs. 2023;47(7):1094\u2013103. https:\/\/doi.org\/10.1111\/aor.14525.","journal-title":"Artif Organs"},{"issue":"1_suppl","key":"480_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/02676591221149859","volume":"38","author":"JM Brewer","year":"2023","unstructured":"Brewer JM, Capoccia M, Maybauer DM, Lorusso R, Swol J, Maybauer MO. The ProtekDuo dual-lumen cannula for temporary acute mechanical circulatory support in right heart failure: a systematic review. Perfusion. 2023;38(1_suppl):59\u201367. https:\/\/doi.org\/10.1177\/02676591221149859.","journal-title":"Perfusion"},{"issue":"11","key":"480_CR38","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/phar.2629","volume":"41","author":"CJ Beavers","year":"2021","unstructured":"Beavers CJ, DiDomenico RJ, Dunn SP, et al. Optimizing anticoagulation for patients receiving Impella support. Pharmacotherapy. 2021;41(11):932\u201342. https:\/\/doi.org\/10.1002\/phar.2629.","journal-title":"Pharmacotherapy"},{"key":"480_CR39","volume-title":"Impella RP system: instructions for use and clinical reference manual","author":"Abiomed Inc.","year":"2017","unstructured":"Abiomed Inc. Impella RP system: instructions for use and clinical reference manual. Danvers: Abiomed Inc.; 2017."},{"key":"480_CR40","unstructured":"Ferrera F, Beavers CJ, Latif F. Impella anticoagulation management in the CCU. 2026. Society of Cardiovascular angiography & Interventions (SCAI). https:\/\/www.scai.org\/quality-improvement-tools\/qi-tips\/impella-anticoagulation-management-ccu. Accessed 3 Aug 2026."},{"issue":"22","key":"480_CR41","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","volume":"2","author":"A Cuker","year":"2018","unstructured":"Cuker A, Arepally GM, Chong BH, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018;2(22):3360\u201392. https:\/\/doi.org\/10.1182\/bloodadvances.2018024489.","journal-title":"Blood Adv"},{"issue":"12","key":"480_CR42","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1016\/j.jtha.2023.08.013","volume":"21","author":"JH Levy","year":"2023","unstructured":"Levy JH, Sniecinski RM, Rocca B, et al. Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis. J Thromb Haemost. 2023;21(12):3649\u201357. https:\/\/doi.org\/10.1016\/j.jtha.2023.08.013.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"480_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytad231","volume":"7","author":"E Merino","year":"2023","unstructured":"Merino E, Abdelfattah OM. Tissue plasminogen activator for axillary Impella 5.0 with heparin-induced thrombocytopenia as a treatment of choice for acute Impella thrombosis: a case report. Eur Heart J Case Rep. 2023;7(5):ytad231. https:\/\/doi.org\/10.1093\/ehjcr\/ytad231.","journal-title":"Eur Heart J Case Rep"},{"issue":"5","key":"480_CR44","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1631\/jzus.2003.0607","volume":"4","author":"J Chen-yang","year":"2003","unstructured":"Chen-yang J, Li-li Z, Jian-an W, Jiang S, Balgaith M. Anticoagulation therapy in intra-aortic balloon counterpulsation: does IABP really need anti-coagulation? J Zhejiang Univ Sci A. 2003;4(5):607\u201311. https:\/\/doi.org\/10.1631\/jzus.2003.0607.","journal-title":"J Zhejiang Univ Sci A"},{"issue":"4","key":"480_CR45","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/17482940802483048","volume":"10","author":"HA Cooper","year":"2008","unstructured":"Cooper HA, Thompson E, Panza JA. The role of heparin anticoagulation during intra-aortic balloon counterpulsation in the coronary care unit. Acute Card Care. 2008;10(4):214\u201320. https:\/\/doi.org\/10.1080\/17482940802483048.","journal-title":"Acute Card Care"},{"issue":"2","key":"480_CR46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/clc.20297","volume":"32","author":"A Laish\u2010Farkash","year":"2009","unstructured":"Laish\u2010Farkash A, Hod H, Matetzky S, Guetta V. Safety of intra\u2010aortic balloon pump using glycoprotein IIb\/IIIa antagonists. Clin Cardiol. 2009;32(2):99\u2013103. https:\/\/doi.org\/10.1002\/clc.20297.","journal-title":"Clin Cardiol"},{"issue":"4","key":"480_CR47","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006666","volume":"13","author":"N Uriel","year":"2020","unstructured":"Uriel N, Jeevanandam V, Imamura T, et al. Clinical outcomes and quality of life with an ambulatory counterpulsation pump in advanced heart failure patients: results of the multicenter feasibility trial. Circ Heart Fail. 2020;13(4):e006666. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.119.006666.","journal-title":"Circ Heart Fail"},{"issue":"3","key":"480_CR48","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4103\/aca.aca_53_21","volume":"25","author":"S Karuppiah","year":"2022","unstructured":"Karuppiah S, Remskar M, Prielipp R. Management of patients with the intravascular ventricular assist system (iVAS) for non-cardiac surgery. Ann Card Anaesth. 2022;25(3):349\u201352. https:\/\/doi.org\/10.4103\/aca.aca_53_21.","journal-title":"Ann Card Anaesth"},{"issue":"14","key":"480_CR49","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.4244\/EIJ-D-16-00371","volume":"12","author":"C Den Uil","year":"2017","unstructured":"Den Uil C, Daemen J, Lenzen M, et al. Pulsatile iVAC 2L circulatory support in high-risk percutaneous coronary intervention. EuroIntervention. 2017;12(14):1689\u201396. https:\/\/doi.org\/10.4244\/EIJ-D-16-00371.","journal-title":"EuroIntervention"},{"key":"480_CR50","unstructured":"PulseCath BV. iVAC 2L 17Fr-17 instructions for use. Utrecht: PulseCath BV; 2024."},{"issue":"8","key":"480_CR51","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1182\/blood.2022018096","volume":"143","author":"A Nascimbene","year":"2024","unstructured":"Nascimbene A, Bark D, Smadja DM. Hemocompatibility and biophysical interface of left ventricular assist devices and total artificial hearts. Blood. 2024;143(8):661\u201372. https:\/\/doi.org\/10.1182\/blood.2022018096.","journal-title":"Blood"},{"key":"480_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.132495","volume":"417","author":"L Alfehaid","year":"2024","unstructured":"Alfehaid L, Abdallah G, Kothari S, et al. Evaluation of anti-XA-guided versus APTT-guided management of intravenous unfractionated heparin in patients requiring a durable ventricular assist device. Int J Cardiol. 2024;417:132495. https:\/\/doi.org\/10.1016\/j.ijcard.2024.132495.","journal-title":"Int J Cardiol"},{"issue":"10","key":"480_CR53","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s12471-022-01671-1","volume":"30","author":"K Damman","year":"2022","unstructured":"Damman K, Van Den Broek SAJ, Mecozzi G, et al. Conservative initial postoperative anticoagulation strategy after HeartMate 3 left ventricular assist device implantation. Neth Heart J. 2022;30(10):466\u201372. https:\/\/doi.org\/10.1007\/s12471-022-01671-1.","journal-title":"Neth Heart J"},{"issue":"5","key":"480_CR54","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003709","volume":"10","author":"M Andreas","year":"2017","unstructured":"Andreas M, Moayedifar R, Wieselthaler G, et al. Increased thromboembolic events with dabigatran compared with vitamin K antagonism in left ventricular assist device patients: a randomized controlled pilot trial. Circ Heart Fail. 2017;10(5):e003709. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.116.003709.","journal-title":"Circ Heart Fail"},{"issue":"11","key":"480_CR55","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.cardfail.2024.05.005","volume":"30","author":"I Netuka","year":"2024","unstructured":"Netuka I, Tucanova Z, Mehra MR. Direct oral anticoagulant therapy with a fully magnetically levitated LVAD and bridging to heart transplantation: a DOT-HM3 study analysis. J Cardiac Fail. 2024;30(11):1512\u20135. https:\/\/doi.org\/10.1016\/j.cardfail.2024.05.005.","journal-title":"J Cardiac Fail"},{"issue":"9","key":"480_CR56","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.jchf.2024.04.013","volume":"12","author":"P Shah","year":"2024","unstructured":"Shah P, Looby M, Dimond M, Bagchi P, Shah B, Isseh I, et al. Evaluation of the hemocompatibility of the direct oral anticoagulant apixaban in left ventricular assist devices: the DOAC LVAD study. JACC Heart Fail. 2024;12(9):1540\u20139. https:\/\/doi.org\/10.1016\/j.jchf.2024.04.013.","journal-title":"JACC Heart Fail."},{"issue":"6","key":"480_CR57","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/jac5.1081","volume":"2","author":"S Bowman","year":"2019","unstructured":"Bowman S, Weeks P, Chow E, et al. Implementation of pharmacist\u2010managed anticoagulation in patients with continuous flow left ventricular assist devices. J Am Coll Clin Pharm. 2019;2(6):623\u20137. https:\/\/doi.org\/10.1002\/jac5.1081.","journal-title":"J Am Coll Clin Pharm"},{"issue":"12","key":"480_CR58","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1177\/1060028017721241","volume":"51","author":"BS Manzoor","year":"2017","unstructured":"Manzoor BS, Cheng WH, Lee JC, Uppuluri EM, Nutescu EA. Quality of pharmacist-managed anticoagulation therapy in long-term ambulatory settings: a systematic review. Ann Pharmacother. 2017;51(12):1122\u201337. https:\/\/doi.org\/10.1177\/1060028017721241.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"480_CR59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/ijpp\/riaf071","volume":"34","author":"M Wilcock","year":"2026","unstructured":"Wilcock M, Bastian L. Anticoagulant stewardship: an opportunity for community pharmacy. Int J Pharm Pract. 2026;34(1):91\u20133. https:\/\/doi.org\/10.1093\/ijpp\/riaf071.","journal-title":"Int J Pharm Pract"},{"issue":"2","key":"480_CR60","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MAT.0000000000000047","volume":"60","author":"MA Bishop","year":"2014","unstructured":"Bishop MA, Streiff MB, Ensor CR, Tedford RJ, Russell SD, Ross PA. Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center. ASAIO J. 2014;60(2):193\u20138. https:\/\/doi.org\/10.1097\/MAT.0000000000000047.","journal-title":"ASAIO J"},{"issue":"6","key":"480_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/jac5.70220","volume":"9","author":"BM Colvin","year":"2026","unstructured":"Colvin BM, Kunkel L, Bauer A, et al. Comparing pharmacist-managed warfarin versus usual care in HeartMate 3 patients: a multicenter retrospective observational study. J Am Coll Clin Pharm. 2026;9(6):e70220. https:\/\/doi.org\/10.1002\/jac5.70220.","journal-title":"J Am Coll Clin Pharm"},{"issue":"5","key":"480_CR62","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1097\/CCM.0000000000005821","volume":"51","author":"TG Seelhammer","year":"2023","unstructured":"Seelhammer TG, Brokmeier HM, Hamzah M, Wieruszewski PM. Analysis of wholesale drug acquisition and laboratory assessment costs between heparin compared with bivalirudin-based systemic anticoagulation strategies in adult extracorporeal membrane oxygenation. Crit Care Med. 2023;51(5):e115\u201321. https:\/\/doi.org\/10.1097\/CCM.0000000000005821.","journal-title":"Crit Care Med"}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-026-00480-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-026-00480-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-026-00480-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:10:56Z","timestamp":1792152656000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-026-00480-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":62,"alternative-id":["480"],"URL":"https:\/\/doi.org\/10.1007\/s40119-026-00480-6","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"value":"2193-8261","type":"print"},{"value":"2193-6544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"18 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Lama Alfehaid, Mansour Alomran, Ahlam Althobaiti, Abdulmajeed Alshehri, Reem Bahmaid, and Arif Albulushi have nothing to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval and informed consent were not required because this article is a narrative review of previously published literature and does not involve human participants, animals, or identifiable patient data.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}